Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2004 Jul;89(4):F364–F366. doi: 10.1136/adc.2003.041533

Does erythropoietin protect the preterm brain?

T Strunk, C Hartel, C Schultz
PMCID: PMC1721701  PMID: 15210677

Full Text

The Full Text of this article is available as a PDF (93.5 KB).

Figure 1.

Figure 1

Open in a new tab

 Neuroprotective properties of erythropoietin. Contributing mechanisms as well as effects observed in animal studies are depicted. SAH, Subarachnoid haemorrhage.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello Davide, Bigini Paolo, Villa Pia, Mennini Tiziana, Cerami Anthony, Brines Michael L., Ghezzi Pietro. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 2002 Oct 11;952(1):128–134. doi: 10.1016/s0006-8993(02)03239-0. [DOI] [PubMed] [Google Scholar]
  2. Alafaci C., Salpietro F., Grasso G., Sfacteria A., Passalacqua M., Morabito A., Tripodo E., Calapai G., Buemi M., Tomasello F. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur J Pharmacol. 2000 Oct 13;406(2):219–225. doi: 10.1016/s0014-2999(00)00691-9. [DOI] [PubMed] [Google Scholar]
  3. Ambrus J. L., Ambrus C. M., Dembinsky W., Sykes D., Kulaylat M. N., Patel R., Akhter S., Islam A. Thromboembolic disease susceptibility related to red cell membrane fluidity in patients with polycythemia vera and effect of phlebotomies. J Med. 1999;30(5-6):299–304. [PubMed] [Google Scholar]
  4. Assandri R., Egger M., Gassmann M., Niggli E., Bauer C., Forster I., Gorlach A. Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J Physiol. 1999 Apr 15;516(Pt 2):343–352. doi: 10.1111/j.1469-7793.1999.0343v.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berger R., Bender S., Sefkow S., Klingmüller V., Künzel W., Jensen A. Peri/intraventricular haemorrhage: a cranial ultrasound study on 5286 neonates. Eur J Obstet Gynecol Reprod Biol. 1997 Dec;75(2):191–203. doi: 10.1016/s0301-2115(97)00135-8. [DOI] [PubMed] [Google Scholar]
  6. Bernaudin M., Marti H. H., Roussel S., Divoux D., Nouvelot A., MacKenzie E. T., Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab. 1999 Jun;19(6):643–651. doi: 10.1097/00004647-199906000-00007. [DOI] [PubMed] [Google Scholar]
  7. Brines M. L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N. C., Cerami C., Itri L. M., Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10526–10531. doi: 10.1073/pnas.97.19.10526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Buescher U., Hertwig K., Wolf C., Dudenhausen J. W. Erythropoietin in amniotic fluid as a marker of chronic fetal hypoxia. Int J Gynaecol Obstet. 1998 Mar;60(3):257–263. doi: 10.1016/s0020-7292(98)00011-3. [DOI] [PubMed] [Google Scholar]
  9. Casadevall Nicole, Nataf Joelle, Viron Beatrice, Kolta Amir, Kiladjian Jean-Jacques, Martin-Dupont Philippe, Michaud Patrick, Papo Thomas, Ugo Valerie, Teyssandier Irene. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002 Feb 14;346(7):469–475. doi: 10.1056/NEJMoa011931. [DOI] [PubMed] [Google Scholar]
  10. Catania Maria A., Marciano Maria C., Parisi Alessandra, Sturiale Alessio, Buemi Michele, Grasso Giovanni, Squadrito Francesco, Caputi Achille P., Calapai Gioacchino. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol. 2002 Feb 22;437(3):147–150. doi: 10.1016/s0014-2999(02)01292-x. [DOI] [PubMed] [Google Scholar]
  11. Celik Murat, Gökmen Necati, Erbayraktar Serhat, Akhisaroglu Mustafa, Konakc Selman, Ulukus Cagnur, Genc Sermin, Genc Kursad, Sagiroglu Emel, Cerami Anthony. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2258–2263. doi: 10.1073/pnas.042693799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chattopadhyay A., Choudhury T. D., Bandyopadhyay D., Datta A. G. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol. 2000 Feb 15;59(4):419–425. doi: 10.1016/s0006-2952(99)00277-4. [DOI] [PubMed] [Google Scholar]
  13. Dammann O., Leviton A. Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities. J Pediatr. 2000 Apr;136(4):433–438. doi: 10.1016/s0022-3476(00)90004-0. [DOI] [PubMed] [Google Scholar]
  14. Digicaylioglu M., Lipton S. A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature. 2001 Aug 9;412(6847):641–647. doi: 10.1038/35088074. [DOI] [PubMed] [Google Scholar]
  15. Ehrenreich Hannelore, Hasselblatt Martin, Dembowski Christoph, Cepek Lukas, Lewczuk Piotr, Stiefel Michael, Rustenbeck Hans-Heino, Breiter Norbert, Jacob Sonja, Knerlich Friederike. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002 Aug;8(8):495–505. [PMC free article] [PubMed] [Google Scholar]
  16. Genc S., Kuralay F., Genc K., Akhisaroglu M., Fadiloglu S., Yorukoglu K., Fadiloğlu M., Gure A. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci Lett. 2001 Feb 2;298(2):139–141. doi: 10.1016/s0304-3940(00)01716-x. [DOI] [PubMed] [Google Scholar]
  17. Gorio Alfredo, Gokmen Necati, Erbayraktar Serhat, Yilmaz Osman, Madaschi Laura, Cichetti Cinzia, Di Giulio Anna Maria, Vardar Enver, Cerami Anthony, Brines Michael. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A. 2002 Jun 24;99(14):9450–9455. doi: 10.1073/pnas.142287899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Grasso Giovanni, Buemi Michele, Alafaci Concetta, Sfacteria Alessandra, Passalacqua Marcello, Sturiale Alessio, Calapai Gioacchino, De Vico Gionata, Piedimonte Giuseppe, Salpietro Francesco M. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A. 2002 Apr 9;99(8):5627–5631. doi: 10.1073/pnas.082097299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jelkmann W. Biology of erythropoietin. Clin Investig. 1994;72(6 Suppl):S3–10. [PubMed] [Google Scholar]
  20. Junk Anna K., Mammis Antonios, Savitz Sean I., Singh Manjeet, Roth Steven, Malhotra Samit, Rosenbaum Pearl S., Cerami Anthony, Brines Michael, Rosenbaum Daniel M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2002 Jul 18;99(16):10659–10664. doi: 10.1073/pnas.152321399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Juul S. E., Anderson D. K., Li Y., Christensen R. D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res. 1998 Jan;43(1):40–49. doi: 10.1203/00006450-199801000-00007. [DOI] [PubMed] [Google Scholar]
  22. Juul S. E., Harcum J., Li Y., Christensen R. D. Erythropoietin is present in the cerebrospinal fluid of neonates. J Pediatr. 1997 Mar;130(3):428–430. doi: 10.1016/s0022-3476(97)70205-1. [DOI] [PubMed] [Google Scholar]
  23. Juul S. E., Yachnis A. T., Rojiani A. M., Christensen R. D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol. 1999 Mar-Apr;2(2):148–158. doi: 10.1007/s100249900103. [DOI] [PubMed] [Google Scholar]
  24. Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr Suppl. 2002;91(438):36–42. doi: 10.1111/j.1651-2227.2002.tb02904.x. [DOI] [PubMed] [Google Scholar]
  25. Kristal B., Shurtz-Swirski R., Shasha S. M., Manaster J., Shapiro G., Furmanov M., Hassan K., Weissman I., Sela S. Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients. Nephron. 1999;81(4):406–413. doi: 10.1159/000045324. [DOI] [PubMed] [Google Scholar]
  26. Ledbetter D. J., Juul S. E. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg. 2000 Feb;35(2):178–182. doi: 10.1016/s0022-3468(00)90006-x. [DOI] [PubMed] [Google Scholar]
  27. Maier R. F., Böhme K., Dudenhausen J. W., Obladen M. Cord blood erythropoietin in relation to different markers of fetal hypoxia. Obstet Gynecol. 1993 Apr;81(4):575–580. [PubMed] [Google Scholar]
  28. Maier R. F., Obladen M., Kattner E., Natzschka J., Messer J., Regazzoni B. M., Speer C. P., Fellman V., Grauel E. L., Groneck P. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr. 1998 May;132(5):866–870. doi: 10.1016/s0022-3476(98)70320-8. [DOI] [PubMed] [Google Scholar]
  29. Maier R. F., Obladen M., Scigalla P., Linderkamp O., Duc G., Hieronimi G., Halliday H. L., Versmold H. T., Moriette G., Jorch G. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med. 1994 Apr 28;330(17):1173–1178. doi: 10.1056/NEJM199404283301701. [DOI] [PubMed] [Google Scholar]
  30. Maier Rolf F., Obladen Michael, Müller-Hansen Ingo, Kattner Evelyn, Merz Ulrich, Arlettaz Romaine, Groneck Peter, Hammer Hannes, Kössel Hans, Verellen Gaston. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr. 2002 Jul;141(1):8–15. doi: 10.1067/mpd.2002.124309. [DOI] [PubMed] [Google Scholar]
  31. Meyer M. P., Meyer J. H., Commerford A., Hann F. M., Sive A. A., Moller G., Jacobs P., Malan A. F. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics. 1994 Jun;93(6 Pt 1):918–923. [PubMed] [Google Scholar]
  32. Nagai A., Nakagawa E., Choi H. B., Hatori K., Kobayashi S., Kim S. U. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol. 2001 Apr;60(4):386–392. doi: 10.1093/jnen/60.4.386. [DOI] [PubMed] [Google Scholar]
  33. Newton N. R., Leonard C. H., Piecuch R. E., Phibbs R. H. Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy. J Perinatol. 1999 Sep;19(6 Pt 1):403–406. doi: 10.1038/sj.jp.7200244. [DOI] [PubMed] [Google Scholar]
  34. Ohls R. K., Ehrenkranz R. A., Wright L. L., Lemons J. A., Korones S. B., Stoll B. J., Stark A. R., Shankaran S., Donovan E. F., Close N. C. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics. 2001 Oct;108(4):934–942. doi: 10.1542/peds.108.4.934. [DOI] [PubMed] [Google Scholar]
  35. Ohls R. K. The use of erythropoietin in neonates. Clin Perinatol. 2000 Sep;27(3):681–696. doi: 10.1016/s0095-5108(05)70045-2. [DOI] [PubMed] [Google Scholar]
  36. Ribatti D., Presta M., Vacca A., Ria R., Giuliani R., Dell'Era P., Nico B., Roncali L., Dammacco F. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood. 1999 Apr 15;93(8):2627–2636. [PubMed] [Google Scholar]
  37. Sakanaka M., Wen T. C., Matsuda S., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4635–4640. doi: 10.1073/pnas.95.8.4635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Schultz Christian, Rott Christina, Temming Petra, Schlenke Peter, Möller Jens C., Bucsky Peter. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res. 2002 Mar;51(3):317–322. doi: 10.1203/00006450-200203000-00009. [DOI] [PubMed] [Google Scholar]
  39. Schultz Christian, Temming Petra, Gembruch Ulrich, Strunk Tobias, Bucsky Peter. Polyclonal intravenous immunoglobulin to prevent brain injury in preterm infants. Lancet. 2002 Apr 27;359(9316):1522–1524. doi: 10.1016/S0140-6736(02)08447-7. [DOI] [PubMed] [Google Scholar]
  40. Sela S., Shurtz-Swirski R., Sharon R., Manaster J., Chezar J., Shkolnik G., Shapiro G., Shasha S. M., Merchav S., Kristal B. The polymorphonuclear leukocyte--a new target for erythropoietin. Nephron. 2001 Jul;88(3):205–210. doi: 10.1159/000045991. [DOI] [PubMed] [Google Scholar]
  41. Shannon K. M., Keith J. F., 3rd, Mentzer W. C., Ehrenkranz R. A., Brown M. S., Widness J. A., Gleason C. A., Bifano E. M., Millard D. D., Davis C. B. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics. 1995 Jan;95(1):1–8. [PubMed] [Google Scholar]
  42. Shibata Junpei, Hasegawa Jo, Siemens Hans-Joachim, Wolber Eva, Dibbelt Leif, Li Dechun, Katschinski Dörthe M., Fandrey Joachim, Jelkmann Wolfgang, Gassmann Max. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood. 2003 Feb 6;101(11):4416–4422. doi: 10.1182/blood-2002-09-2814. [DOI] [PubMed] [Google Scholar]
  43. Shingo T., Sorokan S. T., Shimazaki T., Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci. 2001 Dec 15;21(24):9733–9743. doi: 10.1523/JNEUROSCI.21-24-09733.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sirén A. L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A. 2001 Mar 20;98(7):4044–4049. doi: 10.1073/pnas.051606598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sirén A. L., Knerlich F., Poser W., Gleiter C. H., Brück W., Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. 2001 Mar;101(3):271–276. doi: 10.1007/s004010000297. [DOI] [PubMed] [Google Scholar]
  46. Soubasi V., Kremenopoulos G., Diamanti E., Tsantali C., Sarafidis K., Tsakiris D. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr. 1995 Aug;127(2):291–297. doi: 10.1016/s0022-3476(95)70313-6. [DOI] [PubMed] [Google Scholar]
  47. Springborg Jacob Bertram, Ma XiaoDong, Rochat Per, Knudsen Gitte Moos, Amtorp Ole, Paulson Olaf B., Juhler Marianne, Olsen Niels Vidiendal. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol. 2002 Feb;135(3):823–829. doi: 10.1038/sj.bjp.0704521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tefferi A., Solberg L. A., Silverstein M. N. A clinical update in polycythemia vera and essential thrombocythemia. Am J Med. 2000 Aug 1;109(2):141–149. doi: 10.1016/s0002-9343(00)00449-6. [DOI] [PubMed] [Google Scholar]
  49. Vannucci R. C. Hypoxic-ischemic encephalopathy. Am J Perinatol. 2000;17(3):113–120. doi: 10.1055/s-2000-9293. [DOI] [PubMed] [Google Scholar]
  50. Vannucci R. C., Perlman J. M. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics. 1997 Dec;100(6):1004–1014. doi: 10.1542/peds.100.6.1004. [DOI] [PubMed] [Google Scholar]
  51. Wood N. S., Marlow N., Costeloe K., Gibson A. T., Wilkinson A. R. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med. 2000 Aug 10;343(6):378–384. doi: 10.1056/NEJM200008103430601. [DOI] [PubMed] [Google Scholar]
  52. Yamaji R., Okada T., Moriya M., Naito M., Tsuruo T., Miyatake K., Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem. 1996 Jul 15;239(2):494–500. doi: 10.1111/j.1432-1033.1996.0494u.x. [DOI] [PubMed] [Google Scholar]
  53. Yoon B. H., Romero R., Yang S. H., Jun J. K., Kim I. O., Choi J. H., Syn H. C. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 1996 May;174(5):1433–1440. doi: 10.1016/s0002-9378(96)70585-9. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES